Abstract:Somatostatin inhibits gastroenteropancreatic exocrine secretion and is often used after pancreaticoduodenectomy to reduce pancreatic secretion to minimize tissue damage and pancreatic stump complications. Because our earlier clinical work saw a major increase in delayed gastric emptying (DGE) with somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy (PPPD), this small-group study was designed to confirm or disprove that observation. From August 1997 to December 2000, a total of 23 post-PPPD patients were randomized to receive somatostatin prophylaxis [somatostain (+)] (n = 11) or not [somatostatin] (-) (n = 12). The incidence of DGE, scintographic solid-phase emptying results on day 14 postoperatively, and sequential fasting plasma motilin levels were compared, as motilin levels are related to both gastric motility and somatostatin levels. The somatostatin(+) group exhibited greatly increased patient complaints of DGE: 9 of 11 (82%) versus 3 of 12 (25%) in the somatostatin(-) group. Radiologic scintography showed somatostatin prophylaxis prolonged the half-time (T(1/2)) of solid-phase emptying: 144.5 +/- 51.4 minutes for somatostatin(+) versus 89.0 +/- 59.9 minutes for somatostatin(-) (p < 0.001). Comparing pre-PPPD and post-PPPD plasma motilin levels prior to somatostatin infusion, motilin decreased 80% in reaction to the surgery. For somatostatin(-) patients, motilin levels oscillated, or "rang," postoperatively, reaching a higher level on day 3, declined to a new record minimum on day 7, and by day 21 were 50% of the original and the slope of the recovery curve was increasing well. In somatostatin(+) patients the same ringing pattern was observed but decreased with motilin levels 30% to 70% lower than in the somatostatin(-) patients. By day 21 somatostatin(+) motilin levels were recovering but still only 20% original levels, and the slope of the recovery curve was not optimistic. On postoperative day 14 the plasma motilin levels (below approximately 6 bg/ml) correlated strongly with DGE for both groups. Despite the small sample size, the results indicated that (1) somatostatin prophylaxis significantly decreases fasting plasma motilin; (2) somatostatin prophylaxis produces lingering suppression of plasma motilin; (3) PPPD surgery itself significantly reduces fasting motilin levels with recovery to 50% normal at day 21; (4) the mechanism of somatostatin-induced DGE seems related to reduced fasting plasma motilin levels.

Effect of Somatostatin in Advanced Gastric Cancer after D2 Radical Gastrectomy

APPLICATION OF SOMATOSTATIN FOR THE PREVENTION OF COMPLICATIONS FOLLOWING PANCREATODUODENECTOMY

Somatostatin-analog Effect on Pancreatic Fistula after Radical Gastrectomy: a Pilot Randomized Controlled Trial

Randomized, Placebo-Controlled Study of the Efficacy of Preoperative Somatostatin Administration in the Prevention of Postoperative Complications Following Pancreaticoduodenectomy.

Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin

Curative effect observation of somatostatin in the non-surgical treatment of malignant bowel obstruction caused by gastroenteric tumor

A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy

The Effect of Somatostatin on the Internal Environment in Patients with Intestinal Obstruction

Somatostatin Prevents Clinically Relevant Pancreatic Fistula in Intermediate Risk Patients after Pancreaticoduodenectomy (SPEED): A Multi-center, Randomized, Controlled Study

Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy

Gastrointestinal Tumor Diagnosis and Treatment of Early Postoperative Inlfammatory Intestinal Obstruction

The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer

Clinical study of somatostatin combined with raw vegetable oil in treatment of intestinal obstruction

Impact of Postoperative Complications on Long-Term Survival after Radical Resection for Gastric Cancer

Effect of Somatostatin on Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Hyperamylasemia: A Systematic Review and Meta-Analysis.

Effect of somatostatin on immune inflammatory response in patients with severe acute pancreatitis

The Role of Somatostatin in the Treatment of Early Postoperative Inflammatory Intestinal Obstruction

Conservative Treatment of Early Postoperative Small Bowel Obstruction with Obliterative Peritonitis

The Synergistic Inhibitory Effect of Somatostatin-Doxorubicin Co-Treatment on Gallbladder Carcinoma

Clinical Effect of Early Postoperation Adjuvant Intraperitoneal Chemotherapy of Locally Advanced Gastrie Cancer

Influence of enteral nutrition combined with somatostatin on postoperative rehabilitation of patients with pancreatic surgery